Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Clinical trial NCT04807777 · TERMINATED
Trial details
- NCT number
- NCT04807777
- Sponsor
- Columbia University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-07
- Primary completion
- 2023-04-04
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.